MarketPulse

investor harm

389 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Nektar Therapeutics Hit With Class Action Over Alleged Trial Misstatements

Class action filed against Nektar Therapeutics alleging false trial statements regarding REZOLVE-AA enrollment. Lead plaintiff deadline: May 5, 2026.
NKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Corcept Therapeutics Faces Class Action Over Relacorilant Clinical Trial Claims

Class action filed against $CORP alleging securities fraud over misleading statements about relacorilant clinical trials and FDA regulatory prospects.
CORTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Faces Class Action Over Alleged Misstatements on Book-to-Bill Ratio

Class action lawsuit filed against $MDPC alleging executives made false statements about book-to-bill ratio from April 2025 to February 2026, claiming overstated business prospects.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Class Action Lawsuit Targets Lufax Over Alleged Securities Fraud and Control Failures

Lufax ($LU) faces class action lawsuit alleging securities fraud, financial misstatement, and inadequate internal controls spanning April 2023 to January 2025. Lead plaintiff deadline set for May 20, 2026.
LUsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Super Micro Computer Faces Class Action Over Hidden China Sales and Export Violations

Class action lawsuit filed against $SMCI alleging undisclosed Chinese sales violating export controls and concealed compliance weaknesses. Lead plaintiff deadline set for May 26, 2026.
SMCIsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Trip.com Faces Class Action Over Alleged Monopoly Risk Disclosure Failures

Trip.com faces class action lawsuit alleging false regulatory risk disclosures regarding monopolistic practices. Lead plaintiff deadline set for May 11, 2026.
TCOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Class Action Filed Against Power Solutions Over Data Center Claims, Investor Window Closing

Class action lawsuit filed against $PSIX alleging false statements about data center demand and manufacturing capacity costs. Lead plaintiff deadline May 19, 2026.
PSIXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Aldeyra Faces Class Action Over Reproxalap Trial Data Misstatements

Class action filed against $ALDYA alleging false statements about reproxalap trial results. Eligible investors covered Nov 2023-Mar 2026.
ALDXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Medpace Hit With Class Action Over Alleged Misleading Book-to-Bill Claims

Class action lawsuit filed against Medpace Holdings alleging executives made false statements about financial metrics from April 2025 to February 2026.
MEDPsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Corcept Faces Securities Fraud Lawsuit Over Relacorilant Trial Misstatements

Class action lawsuit filed against Corcept Therapeutics alleging securities fraud over misleading statements about relacorilant clinical trials and FDA approval prospects.
CORTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Class Action Alleges Atara Biotherapeutics Concealed Manufacturing and Trial Defects

Class action lawsuit filed against Atara Biotherapeutics for allegedly misrepresenting manufacturing issues and ALLELE study deficiencies affecting tabelecleucel approval prospects.
ATRAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Class Action Lawsuit Targets REGENXBIO Over RGX-111 Gene Therapy Disclosures

Investors in $REGENXBIO face class action lawsuit alleging false statements about RGX-111 gene therapy development and clinical trial results spanning 2022-2026.
RGNXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Aquestive Therapeutics Hit With Securities Fraud Suit Over Anaphylm FDA Timeline Claims

Class action lawsuit filed against Aquestive Therapeutics alleging securities fraud related to Anaphylm FDA approval timeline and undisclosed human factors risks.
AQSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Gemini Space Station Hit With Securities Fraud Class Action Over Crypto Platform Claims

Class action lawsuit filed against $GEMI alleging securities fraud over overstated crypto platform viability and expansion prospects during IPO period.
GEMIsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Soleno Therapeutics Hit With Securities Fraud Class Action Over Undisclosed Drug Safety Issues

Soleno Therapeutics faces class action lawsuit alleging failure to disclose material DCCR drug safety concerns, including excess fluid retention in clinical trials that reduced commercial viability.
SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

NuScale Faces Class Action Over ENTRA1 Partnership Claims

Class action lawsuit filed against NuScale Power alleging false statements about partner ENTRA1's nuclear experience, claiming hundreds of millions at risk.
SMRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

$TCOM Faces Class Action Over Alleged Regulatory Risk Concealment

Trip.com faces class action lawsuit alleging false statements about regulatory risks tied to monopolistic practices during April 2024-January 2026 period.
TCOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Boston Scientific Faces Class Action Over Electrophysiology Segment Disclosures

Boston Scientific faces class action lawsuit alleging management concealed adverse trends in electrophysiology segment's procedure volumes and competitive pressures from July 2025 to February 2026.
BSXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Power Solutions International Faces Class Action Over Data Center Claims, Investor Window Closes May 19

Class action filed against $PSIX alleging false data center statements and understated capacity costs. Investors have until May 19, 2026 to join lawsuit.
PSIXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Snowflake Hit With Securities Fraud Class Action Over Undisclosed Efficiency Impact

Class action lawsuit filed against $SNOW alleges securities fraud over undisclosed product efficiency gains and pricing changes affecting revenues during mid-2023 to early-2024 period.
SNOWsecurities fraudclass action lawsuit